All Stories

  1. Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial

    Article • Journal of the American Heart Association, October 2018, Wolters Kluwer Health

    Dr Robert John Mentz

  2. The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes

    Article • Clinical Cardiology, September 2018, Wiley

    Dr Robert John Mentz

  3. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial

    Article • ESC Heart Failure, August 2018, Wiley

    Dr Robert John Mentz

  4. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF

    Article • Clinical Cardiology, July 2018, Wiley

    Dr Robert John Mentz

  5. Hyperkalemia in Heart Failure: Probably Not O“K”

    Article • Journal of the American Heart Association, May 2018, Wolters Kluwer Health

    Dr Robert John Mentz

  6. Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decomp...

    Article • Journal of the American Heart Association, February 2018, Wolters Kluwer Health

    Dr Robert John Mentz

  7. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

    Article • European Journal of Heart Failure, October 2015, Wiley

    Dr Robert John Mentz, Professor john j mcmurray

  8. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial

    Article • European Journal of Heart Failure, June 2015, Wiley

    Dr Robert John Mentz, Professor John GF Cleland

  9. The Palliative Care in Heart Failure Trial: Rationale and design

    Article • American Heart Journal, November 2014, Elsevier

    Dr Robert John Mentz

  10. Charting a Roadmap for Heart Failure Biomarker Studies

    Article • JACC Heart Failure, October 2014, Elsevier

    Dr Robert John Mentz, Professor John GF Cleland

  11. Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)

    Article • The American Journal of Cardiology, September 2014, Elsevier

    Dr Robert John Mentz

  12. Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries

    Article • American Heart Journal, August 2014, Elsevier

    Dr Robert John Mentz, Professor Giuseppe M C Rosano

  13. d-Dimer elevation and adverse outcomes

    Article • Journal of Thrombosis and Thrombolysis, July 2014, Springer Science + Business Media

    Dr Robert John Mentz, Dr Gerald Chi, Gerald Chi

  14. Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events

    Article • European Journal of Heart Failure, June 2014, Wiley

    Dr Robert John Mentz

  15. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

    Article • European Journal of Heart Failure, April 2014, Wiley

    Dr Robert John Mentz, Professor John GF Cleland

  16. Sleep-Disordered Breathing in Patients with Heart Failure

    Article • Heart Failure Clinics, April 2014, Elsevier

    Dr Robert John Mentz

  17. IMPACT OF SEVERE DYSPNEA ON OUTCOMES AND HEALTH CARE COSTS IN PATIENTS HOSPITALIZED WITH HEART FAILURE

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Robert John Mentz

  18. SOCIOECONOMIC STATUS, MARITAL STATUS AND OUTCOMES IN HEART FAILURE: FINDINGS FROM HF-ACTION

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Robert John Mentz

  19. DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Robert John Mentz

  20. RELIABLE EVALUATION OF DYSPNEA (RED-ROSE): A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Robert John Mentz

  21. THE WORST SYMPTOM VISUAL ANALOGUE SCALE: A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Robert John Mentz

  22. Decongestion in acute heart failure

    Article • European Journal of Heart Failure, March 2014, Wiley

    Dr Robert John Mentz, Professor John GF Cleland

  23. Patient Selection for Advanced Heart Failure Therapy Referral

    Article • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine, March 2014, Wolters Kluwer Health

    Dr Robert John Mentz

  24. Medical Management of Patients With Continuous-Flow Left Ventricular Assist Devices

    Article • Current Treatment Options in Cardiovascular Medicine, January 2014, Springer Science + Business Media

    Dr Robert John Mentz

  25. Heart Failure With Preserved Ejection Fraction

    Article • Journal of the American College of Cardiology, January 2014, Elsevier

    Dr Robert John Mentz

  26. Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

    Article • European Journal of Heart Failure, December 2013, Wiley

    Dr Robert John Mentz

  27. Relation of Serum Magnesium Levels and Postdischarge Outcomes in Patients Hospitalized for Heart Failure (from the EVEREST Trial)

    Article • The American Journal of Cardiology, December 2013, Elsevier

    Dr Robert John Mentz

  28. A Crisis of the Heart

    Article • ASAIO Journal, November 2013, Wolters Kluwer Health

    Dr Robert John Mentz

  29. Learning from recent trials and shaping the future of acute heart failure trials

    Article • American Heart Journal, October 2013, Elsevier

    Dr Robert John Mentz

  30. The past, present and future of renin–angiotensin aldosterone system inhibition

    Article • International Journal of Cardiology, September 2013, Elsevier

    Dr Robert John Mentz, Professor john j mcmurray

  31. Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION)

    Article • American Heart Journal, September 2013, Elsevier

    Dr Robert John Mentz

  32. Previous Hospitalizations Predict Worse Outcomes after Discharge Despite Achievement of Diuresis during ADHF Hospitalization

    Article • Journal of Cardiac Failure, August 2013, Elsevier

    Dr Robert John Mentz

  33. Funding opportunities for clinical investigators in the early stages of career development in cardiovascular research

    Article • Journal of Thrombosis and Thrombolysis, July 2013, Springer Science + Business Media

    Dr Robert John Mentz

  34. Noncardiac Comorbidities and Acute Heart Failure Patients

    Article • Heart Failure Clinics, July 2013, Elsevier

    Dr Robert John Mentz

  35. Heart failure in elderly patients: distinctive features and unresolved issues

    Article • European Journal of Heart Failure, July 2013, Wiley

    Dr Robert John Mentz

  36. Dysphagia in the Setting of Left Ventricular Assist Device Hemolysis

    Article • ASAIO Journal, May 2013, Wolters Kluwer Health

    Dr Robert John Mentz

  37. Response to “Global cardiovascular clinical trials and geographic altitude”

    Article • American Heart Journal, April 2013, Elsevier

    Dr Robert John Mentz

  38. Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF

    Article • European Journal of Heart Failure, April 2013, Wiley

    Dr Robert John Mentz

  39. ASSOCIATION BETWEEN ANGINA AND OUTCOMES IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: ANALYSIS FROM THE DUKE DATABANK FOR CARDIOVASCULAR DISEASE

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Robert John Mentz

  40. MINERALOCORTICOID RECEPTOR ANTAGONISTS IN DIABETIC PATIENTS HOSPITALIZED WITH HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Robert John Mentz

  41. PROGNOSTIC ROLE OF HEMOCONCENTRATION IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: AN ANALYSIS OF THE EVEREST TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Robert John Mentz

  42. SERUM MAGNESIUM LEVELS AND POSTDISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Robert John Mentz

  43. INFLUENCE OF URIC ACID LEVEL IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM THE EVEREST TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Robert John Mentz

  44. Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes

    Article • Journal of the American College of Cardiology, February 2013, Elsevier

    Dr Robert John Mentz

  45. Association of Beta-Blocker Use and Selectivity With Outcomes in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease (from OPTIMIZE-HF)

    Article • The American Journal of Cardiology, February 2013, Elsevier

    Dr Robert John Mentz

  46. Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

    Article • The American Journal of Cardiology, February 2013, Elsevier

    Dr Robert John Mentz

  47. Association between diabetes mellitus and post‐discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

    Article • European Journal of Heart Failure, February 2013, Wiley

    Dr Robert John Mentz

  48. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST...

    Article • American Heart Journal, February 2013, Elsevier

    Dr Robert John Mentz

  49. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)

    Article • American Heart Journal, February 2013, Elsevier

    Dr Robert John Mentz

  50. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial

    Article • European Journal of Heart Failure, January 2013, Wiley

    Dr Robert John Mentz

  51. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

    Article • American Heart Journal, December 2012, Elsevier

    Dr Robert John Mentz

  52. Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)

    Article • The American Journal of Cardiology, December 2012, Elsevier

    Dr Robert John Mentz

  53. Reply

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Dr Robert John Mentz

  54. Implications of geographical variation on clinical outcomes of cardiovascular trials

    Article • American Heart Journal, September 2012, Elsevier

    Dr Robert John Mentz

  55. The Impact of Chronic Obstructive Pulmonary Disease in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction: An Analysis of the EVEREST Trial

    Article • Journal of Cardiac Failure, July 2012, Elsevier

    Dr Robert John Mentz

  56. Diuretics and Ultrafiltration in Acute Decompensated Heart Failure

    Article • Journal of the American College of Cardiology, June 2012, Elsevier

    Dr Robert John Mentz

  57. The PROTECT in‐hospital risk model: 7‐day outcome in patients hospitalized with acute heart failure and renal dysfunction

    Article • European Journal of Heart Failure, June 2012, Wiley

    Dr Robert John Mentz, Professor John GF Cleland

  58. Bronchodilators in Heart Failure Patients With COPD: Is It Time for a Clinical Trial?

    Article • Journal of Cardiac Failure, May 2012, Elsevier

    Dr Robert John Mentz

  59. Comparison of Clinical Characteristics and Long-Term Outcomes of Patients With Ischemic Cardiomyopathy With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)

    Article • The American Journal of Cardiology, May 2012, Elsevier

    Dr Robert John Mentz

  60. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE‐HF

    Article • European Journal of Heart Failure, April 2012, Wiley

    Dr Robert John Mentz

  61. CLINICAL CHARACTERISTICS, RESPONSE TO EXERCISE AND OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM HEART FAILURE – A CONTROLLED TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAINING (HF-ACTION)

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Dr Robert John Mentz

  62. THE ASSOCIATION OF BETA-BLOCKER USE AND SELECTIVITY WITH OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM THE ORGANIZED PROGRAM TO INITIATE LIFE-SAVING TREATMENT IN HOSPITALIZED PATIENTS WITH HEART FAILURE

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Dr Robert John Mentz

  63. Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction

    Article • The Journal of Heart and Lung Transplantation, January 2012, Elsevier

    Dr Robert John Mentz

  64. Cardiorenal Syndrome Clinical Trial End Points

    Article • Heart Failure Clinics, October 2011, Elsevier

    Dr Robert John Mentz

  65. Covariate Adjustment in Heart Failure Randomized Controlled Clinical Trials: A Case Analysis of the HF-ACTION Trial

    Article • Heart Failure Clinics, October 2011, Elsevier

    Dr Robert John Mentz

  66. Epidemiology of Cardiorenal Syndrome

    Article • Cardiology Clinics, May 2011, Elsevier

    Dr Robert John Mentz

  67. Natriuretic Peptide-Guided Therapy for Heart Failure

    Article • Circulation Journal, January 2011, Japanese Circulation Society

    Dr Robert John Mentz

  68. Epidemiology of Cardiorenal Syndrome

    Article • Heart Failure Clinics, July 2010, Elsevier

    Dr Robert John Mentz